Search

everythinglearnresearchcommunity

for

Search:↓

A protein called EGFR protects hair follicle stem cells, and when it's disrupted, hair follicles can be damaged, but blocking certain pathways can restore hair growth.

EGFR deficiency causes significant changes in skin cells and hair follicles.

EGFR inhibitors cause skin issues and hair loss by weakening skin defenses, suggesting antibiotics and targeted treatments can help.

Cancer treatment drugs can cause permanent hair loss by damaging hair follicle stem cells, but a specific inhibitor might reverse this effect.

Some lung cancer patients treated with EGFR inhibitors may develop a hair loss condition similar to folliculitis decalvans.

Dr. Mario Lacouture recommends preventive and specific treatments for skin side effects caused by EGFR inhibitors to improve patients' quality of life.

Some new isatin compounds could be strong cancer-fighting drugs because they fit well in cancer-related proteins and have good drug-like properties.

EGFR is essential for normal hair development and follicle differentiation.

PRIDE syndrome includes skin and hair issues from cancer treatment with EGFR inhibitors.

Skin side effects from cancer drugs targeting EGFR can affect treatment adherence but can be managed with antibiotics like tetracycline.

EGFR inhibitors can cause various skin issues during cancer treatment, and managing these is important for patient care.

EGFR inhibitors can cause yellowish skin eruptions.

EGFR helps mouse hair follicles stop growing by reducing certain growth regulators.

Doxycycline can effectively treat hair loss caused by EGFR inhibitors.

A new method quickly detects hair changes from EGFR inhibitors using a microscope.

Certain gene variations in EGF and EGFR may increase the risk of alopecia areata in Koreans.

You might not need to stop cancer treatment if you get a rare skin reaction from EGFR inhibitors, as skin treatments can help manage it.

Blocking EGFR can lead to hair loss due to inflammation and stem cell damage.

EGFR is crucial for preventing hair follicle inflammation and hair loss.

Genetic testing for EGFR mutations is crucial in similar cases.

Pemetrexed is as effective as docetaxel but has fewer side effects for treating nonsmall-cell lung cancer after EGFR-TKI therapy failure.

EGF controls hair growth by regulating hair follicles' growth phases.

EGF and KGF signalling prevent hair follicle formation and promote skin cell development in mice.

Cetuximab can cause excessive eyelash growth.

Combining irinotecan and cetuximab is effective for some metastatic colorectal cancer patients but often causes manageable skin issues.

A cancer patient died from a severe skin reaction after taking the drug cetuximab.

Cetuximab can cause eyelash growth, which is rare but manageable.

Blocking Wnt/β-catenin signaling with EGF receptor is necessary for proper hair growth.

Allopregnanolone increases growth and changes gene activity in human brain cancer cells.

Genetic changes in mice help understand skin and hair disorders, aiding treatment development for acne and hair loss.